Frontier Wealth Management’s Novo Nordisk NVO Stock Holding History

Frontier Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-37,262	Closed	-$858K	–	378
2018 Q4	$858K	Buy	37,262 +248	+0.7%	+$5.51K	0.13%	153
2018 Q3	$872K	Hold	37,014	–	–	0.08%	163
2018 Q2	$854K	Hold	37,014	–	–	0.12%	158
2018 Q1	$911K	Buy	37,014 +14	+0%	+$368	0.13%	160
2017 Q4	$993K	Hold	37,000	–	–	0.16%	142
2017 Q3	$891K	Hold	37,000	–	–	0.13%	164
2017 Q2	$793K	Hold	37,000	–	–	0.12%	170
2017 Q1	$634K	Buy	37,000 +4,000	+12%	+$69.7K	0.1%	195
2016 Q4	$592K	Buy	+33,000	New	+$598K	0.1%	195

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Frontier Wealth Management's NVO Position: Q1 2019 in Review

Frontier Wealth Management sold out of Novo Nordisk (NVO) in Q1 2019, closing a stake of 37,262 shares — an estimated $858K sold.

Frontier Wealth Management first reported a position in NVO in Q4 2016 and held it in 9 quarters. The position peaked at $993K in Q4 2017. 580 funds tracked by Wall St. Rank hold NVO as of Q1 2019.

Frontier Wealth Management reported no remaining Novo Nordisk position as of Q1 2019 after selling out during the quarter.
Frontier Wealth Management sold 37,262 Novo Nordisk shares in Q1 2019, an estimated $858K.
Frontier Wealth Management first reported a position in Novo Nordisk in Q4 2016 and held it in 9 quarters.
Frontier Wealth Management's Novo Nordisk position peaked at $993K in Q4 2017.
580 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2019.

Based on Frontier Wealth Management's 13F filing for Q1 2019, filed 15 May 2019.